FDA,GMP,ICH临床实验专业英语词汇互译

FDA,GMP,ICH临床实验专业英语词汇互译 FDA常用词中英对照

FDA(food and drug adminisration)美国)食品药品监督管理局 NDA(new drug application):新药申请

ANDA(abbreviated new drug application):简化新药申请

EP(export application):出口药申请(申请出口不被批准在美国销售的药品) treatment IND:研究中的新药用于治疗 abbreviated(new)drug:简化申请的新药 DMF(drug master file):药物主文件(持有者为谨慎起见而准备的保密资料,可以包括一个或多个人用药物在制备,加工,包装和贮存过程中所涉及的设备,生产过程或物品.只有在DMF持有者或授权代表以授权书的形式授权给FDA,FDA在审查IND, NDA,ANDA时才能参考其内容)

holderMF持有者

CFR(code of federal regulation)美国)联邦法规 PANEL:专家小组

batch production:批量生产;分批生产 batch production records:生产批号记录

post or pre-market surveillance:销售前或销售后监督

informed consent:知情同意(患者对治疗或受试者对医疗试验了解后表示同意接 受治疗或试验)

prescription drug:处方药

OTC drug(over—the—counter drug):非处方药 U.S. public health service:美国卫生福利部

NIH(national institute of health)美国)全国卫生研究所 animal trail:动物试验

accelerated approval:加速批准 standard drug:标准药物

investigator :研究人员;调研人员

preparing and submitting:起草和申报 submission:申报;递交 benefit(s):受益 risk(s):受害

drug product:药物产品 drug substance:原料药

established name:确定的名称 generic name:非专利名称 proprietary name:专有名称;

INN(international nonproprietary name):国际非专有名称 narrative summary: 记叙体概要 adverse effect:副作用

adverse reaction:不良反应 protocol:方案

archival copy:存档用副本 review copy:审查用副本

official compendium:法定药典(主要指USP, NF).

USP(the united state pharmacopeia):美国药典(现已和NF合并一起出版) NF(national formulary)美国)国家药品集

official=pharmacopeial = compendial:药典的;法定的;官方的 agency:审理部门(指FDA)

sponsor:主办者(指负责并着手临床研究者) identity:真伪;鉴别;特性

strength:规格;规格含量(每一剂量单位所含有效成分的量) labeled amount:标示量

regulatory specification:质量管理规格标准(NDA提供)

regulatory methodology:质量管理方法(FDA用于考核原料药或药物产品是否符合批准了的质量管理规格标准的整套步骤)

regulatory methods validation:管理用分析方法的验证(FDA对NDA提供的方法进行验证)

Dietary supplement:食用补充品

ICH(International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use)人用药物注册技术要求国际协调会议 ICHuality-质量

Q1A(R2): Stability Testing of New Drug Substances and Products (Second Revision) 新原料药和制剂的稳定性试验(第二版)

Q1B: Photostability Testing of New Drug Substances and Products 新原料药和制剂的光稳定性试验

Q1C: Stability Testing for New Dosage Forms 新制剂的稳定性试验

Q1D: Bracketing and Matrixing Designs for Stability Testing of Drug Substances and Drug Products

原料药和制剂稳定性试验的交叉和矩阵设计 Q1E: Evaluation of Stability Data 对稳定性数据的评估处理

Q1F: Stability Data Package for Registration Applications in Climatic Zones III and IV

在气候带III和IV,药物注册申请所提供的稳定性数据 Q2A: Text on Validation of Analytical Procedures 分析程序的验证

Q2B: Validation of Analytical Procedures: Methodology 分析程序的验证:方法学

Q3A(R): Impurities in New Drug Substances (Revised Guideline) 新原料药中的杂质(修订版)

Q3B(R): Impurities in New Drug Products (Revised Guideline) 新制剂中的杂质(修订版)

Q3C: Impurities: Guideline for Residual Solvents 杂质:残留溶剂指南

Q3C(M): Impurities: Guideline for Residual Solvents (Maintenance) 杂质:残留溶剂指南(修改内容) Q4: Pharmacopoeias药典

Q4A: Pharmacopoeial Harmonisation 药典的协调

Q4B: Regulatory Acceptance of Pharmacopoeial Interchangeability 药典互替在法规上的可接受性

Q5A: Viral Safety Evaluation of Biotechnology Products Derived from Cell Lines of Human or Animal Origin

来源于人或者动物细胞系的生物技术产品的病毒安全性评估

Q5B: Quality of Biotechnological Products: Analysis of the Expression Construct in Cells Used for Production of r-DNA Derived Protein Products

生物技术产品的质量:源于重组DNA的蛋白质产品的生产中所用的细胞中的表达构建分析 Q5C: Quality of Biotechnological Products: Stability Testing of Biotechnological/Biological Products

生物技术产品的质量:生物技术/生物产品的稳定性试验

Q5D: Derivation and Characterisation of Cell Substrates Used for Production of Biotechnological/Biological Products

用于生产生物技术/生物产品的细胞底物的起源和特征描述

Q5E: Comparability of Biotechnological/Biological Products Subject to Changes in Their Manufacturing Process

基于不同生产工艺的生物技术产品/生物产品的可比较性

Q6: Specifications for New Drug Substances and Products 新原料药和制剂的质量规格 Q6A: Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances

质量规格:新原料药和新制剂的检验程序和可接收标准:化学物质

Q6B: Specifications: Test Procedures and Acceptance Criteria for Biotechnological/Biological Products

质量规格:生物技术/生物产品的检验程序和可接收标准 -- 作者:月萝兰魂

-- 发布时间:2006-12-22 13:34:00 --

Q7: Good Manufacturing Practices for Pharmaceutical Ingredients 活性药物成份的GMP

Q7A: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients 活性药物成份的GMP指南

Q8: Pharmaceutical Development 药物研发

Q9: Quality Risk Management 质量风险管理 ICH:Safety-安全

S1A: Guideline on the Need for Carcinogenicity Studies of Pharmaceuticals 药物致癌性研究需要的指南

S1B: Testing for Carcinogenicity of Pharmaceuticals

药物致癌性的检验

S1C: Dose Selection for Carcinogenicity Studies of Pharmaceuticals 药物致癌性研究之剂量选择

S1C(R): Addendum: Addition of a Limit Dose and Related Notes 附录:极限剂量和有关注释的的补充

S2A: Guidance on Specific Aspects of Regulatory Genotoxicity Tests for Pharmaceuticals

受法规管辖的药物基因毒性检验的特定方面的指南

S2B: Genotoxicity: A Standard Battery for Genotoxicity Testing for Pharmaceuticals 基因毒性:药物基因毒性检验的标准

S3A: Note for Guidance on Toxicokinetics: The Assessment of Systemic Exposure in Toxicity Studies

毒物代谢动力学指南的注释:毒性研究中的全身性暴露量的评估

S3B: Pharmacokinetics: Guidance for Repeated Dose Tissue Distribution Studies 药物代谢动力学:重复剂量的组织分布研究指南 S4: Single Dose Toxicity Tests 单剂量毒性检验 S4A: Duration of Chronic Toxicity Testing in Animals (Rodent and Non-Rodent Toxicity Testing)

动物体内慢性毒性持续时间的检验(啮齿动物和非啮齿动物毒性检验)

S5A: Detection of Toxicity to Reproduction for Medicinal Products 药物对生殖发育的毒性的检验

S5B(M): Maintenance of the ICH Guideline on Toxicity to Male Fertility: An Addendum to the Guideline on Detection of Toxicity to Reproduction for Medicinal Products 对男性生殖能力的毒性的指南的变动:药物对生殖发育的毒性的检验指南增加了一个附录 S6: Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals 生物技术生产的药物的临床前安全评价

S7A: Safety Pharmacology Studies for Human Pharmaceuticals 人用药的安全药理学研究

S7B: The Nonclinical Evaluation of the Potential for Delayed Ventricular Repolarization

(QT Interval Prolongation) By Human Pharmaceuticals 药物延迟心室复极化(QT间期)潜在作用的非临床评价

S8: Immunotoxicology Studies for Human Pharmaceuticals 人用药免疫毒理学研究

M3(M): Maintenance of the ICH Guideline on Non-Clinical Safety Studies for the Conduct of Human Clinical Trials for Pharmaceuticals 药物的对人临床试验的非临床安全研究指南的变动 E-Efficacy(有效)

E1: The Extent of Population Exposure to Assess Clinical Safety for Drugs Intended for Long-Term Treatment of Non-Life-Threatening Conditions

对用于无生命危险情况下长期治疗的药物进行临床安全评估的族群暴露量范围

E2A: Clinical Safety Data Management: Definitions and Standards for Expedited Reporting

临床安全数据管理:速报制度的定义和标准 E2B(R): Revision of the E2B(M) ICH Guideline on Clinical Safety Data Management Data Elements for Transmission of Individual Case Safety Reports

个案安全报告送交的临床安全数据管理的数据要素指南(E2B(M))的修订版 E2B (M): Maintenance of the Clinical Safety Data Management including: Data Elements for Transmission of Individual Case Safety Reports 临床安全数据管理的变动包括:个案安全报告送交的数据要素

E2B(M): Maintenance of the Clinical Safety Data Management including Questions and Answers

临床安全数据管理的变动,包括问答

E2C: Clinical Safety Data Management: Periodic Safety Update Reports for Marketed Drugs

临床安全数据管理:已上市药品的周期性安全数据更新报告

Addendum to E2C: Periodic Safety Update Reports for Marketed Drugs E2C的附录:已上市药品的周期性安全数据更新报告

E2D: Post-Approval Safety Data Management: Definitions and Standards for Expedited Reporting

批准后的安全数据管理:速报制度的定义和标准 E2E: Pharmacovigilance Planning 药物警戒计划

E3: Structure and Content of Clinical Study Reports 临床研究报告的结构和内容

E4: Dose-Response Information to Support Drug Registration 支持药品注册的剂量-效应资料

E5: Ethnic Factors in the Acceptability of Foreign Clinical Data 引入海外临床数据时要考虑的人种因素

E6: Good Clinical Practice: Consolidated Guideline GCP:良好的临床规范:统一的指南

E7: Studies in Support of Special Populations: Geriatrics 对特定族群的支持的研究:老人病学

E8: General Considerations for Clinical Trials 对临床试验的总的考虑

E9: Statistical Principles for Clinical Trials 临床试验的统计原则

E10: Choice of Control Group and Related Issues in Clinical Trials 临床试验中控制组和有关课题的选择

E11: Clinical Investigation of Medicinal Products in the Pediatric Population 小儿科药物的临床调查

E12A: Principles for Clinical Evaluation of New Antihypertensive Drugs 新抗高血压药物的临床评价原则

E14: The Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs

非抗心率失常药物的QT/QTc 间期和致心率失常潜在作用的临床评价 Multidisciplinary Guidelines 多学科兼容的指南

M1: Medical Terminology 医学术语

M2: Electronic Standards for Transmission of Regulatory Information (ESTRI) 药政信息传递之电子标准 M3: Timing of Pre-clinical Studies in Relation to Clinical Trials (See Safety Topics) 有关临床试验的临床前研究的时间安排

M4: The Common Technical Document (See CTD section for complete Status of the guidelines)

通用技术文件(见有关CTD章节)

M5: Data Elements and Standards for Drug Dictionaries 药物词典的数据要素和标准 临床试验常用的英文缩略语

TTP: time-to-progression 疾病进展时间 SAE: severity Adverse Event 严重不良事件 AE: Adverse Event 不良事件 -- 作者:月萝兰魂

-- 发布时间:2006-12-22 13:34:00 --

SOP: Standard Operating Procedure 标准操作规程 CRF: Case Report form 病例报告表 DLT: 剂量毒性 MTD: 最大耐受剂量

KPS: Karnofsky Performance Status行为状态评分 CR: complete response完全缓解 PR: partial response部分缓解 SD: 病情稳定

PD: progressive disease病情进展 CTC: 常用药物毒性标准

IEC: independent ethics committee 伦理委员会 IRB : institutional review board 伦理委员会 CRA: 临床研究助理

CRO: Contract Research Organization 合同研究组织 DFS: Disease Free Survival 无病生存期 OS: (Overall Survival) 总生存时间 IC: Informed consent 知情同意

ADR: Adverse Drug Reaction 不良反应

GAP:Good Agricultural Practice 中药材种植管理规范 GCP:Good Clinical Practice 药物临床试验质量管理规范 GLP:Good Laboratory Practice 药品实验室管理规范

GMP:Good Manufacturing Practice 药品生产质量管理规范 GSP:Good Supply Practice 药品经营质量管理规范 GUP:Good Use Practice 药品使用质量管理规范 PI rincipal investigator 主要研究者 CI: Co-inveatigator 合作研究者

SI :Sub-investigator 助理研究者

COI :Coordinating investigtor 协调研究者 DGMP: 医疗器械生产质量管理规范

ICF: Informed consent form 知情同意书

RCT : randomized controlled trial, 随机对照试验

NRCCT: non-randomized concurrent controlled trial, 非随机同期对照试验 EBM: evidence-based medicine 循证医学

RCD: randomized cross-over disgn 随机交叉对照试验 HCT: historial control trial, 历史对照研究

RECIST: Response Evaluation Criteria In Solid Tumors. 实体瘤疗效反应的评价标准 QC: Quality Control质量控制

UADR: Unexpected Adverse Drug Reaction,非预期药物不良反应 -- 作者:月萝兰魂

-- 发布时间:2006-12-22 13:34:00 -- GMP英语

PIC/S的全称为harmaceutical Inspection Convention/Pharmaceutical Inspection Cooperation Scheme, PIC/S(制药检查草案), 药品检查协会(PIC/S) ,也有人称PIC/S为医药审查会议/合作计划(PIC/S)

PIC的权威翻译:药品生产检查相互承认公约

API(Active Pharmaceutical Ingrediet) 原料药 又称:活性药物组分 AirLock 气闸

Authorized Person 授权人 Batch/Lot 批次

Batch Number/Lot-Number 批号;

Batch Numbering System 批次编码系统; Batch Records 批记录; Bulk Product 待包装品; Calibration 校正; Clean area洁净区;

Consignmecnt(Delivery)托销药品.

ABPI Association of the British Pharmaceutical Industry ADR Adverse Drug Reaction AE Adverse Event

AIM Active Ingredient Manufacturer ANDA Abbreviated New Drug Application ANOVA Analysis of Variance

ASM: Active Substance Manufacturer ATC Anatomical Therapeutic Chemical ATX Animal Test Exemption Certificate BANBritish Approved Name

BIRABritish Institute of Regulatory Affairs BNF British National Formulary BP British Pharmacopoeia

C of A Certificate of Analysis C of S Certificate of Suitability CENTRE FOR DRUG EVALUATION (CDE)

Centre for Pharmaceutical Administration (CPA) CMS Concerned Member State CMS每个成员国

COS Certificate of Suitability

CPMP Committee for Proprietary Medicinal Products CRA Clinical Research Associate CRF Case Report Form

CRO Contract Research Organisation CTA Clinical Trial Application CTC Clinical Trial Certificate CTD Common Technical Document CTX Clinical Trials Exemption DDD Defined Daily Dose

DGC Daily Global Comparison

DIA Drug Information Association DMF Drug Master File

Drug Registration Branch (DR, Product Evaluation & Registration Division, CPA EDQM (European Directorate for the Quality of Medicines) 欧洲联盟药品质量指导委员会

EEA 欧洲经济地区

EGMA European Generics Medicine Association ELA Established Licence Application

EMEA European Medicines Evaluation Agency

EMEA (European Agency for the Evaluation of Medicinal Products) 欧洲联盟药品评价机构

EP European Pharmacopoeia

EPAR European Public Assessment Reports

ESRA European Society of Regulatory Affairs

European Pharmacopoeia Commission 欧洲药典委员会 FDA Food and Drug Administration final evaluation report (FER) free sale certificates (FSCs) Health Sciences Authority (HSA)

HSA's Medicines Advisory Committee (MAC) IB Investigators Brochure

ICH International Conference for Harmonisation IDMC Independent Data-Monitoring Committee IEC Independent Ethics Committee IND Investigational New Drug

INN International Non-proprietary Name

International Conference on Harmonisation (ICH)

IPC In Process Control

IRB Institutional Review Board LICENCE HOLDER

MA Marketing Authorisation

MAA Marketing Authorisation Application MAA上市申请

MAH Marketing Authorisation Holder MAH 销售许可持有者

MCA Medicines Control Agency

MHW Ministry of Health and Welfare (Japan) MR Mutual Recognition

MRA 美国与欧盟的互认协议

MRAs (Mutual Recognition Agreements) 互相认证同意 MRFG Mutual Recognition Facilitation Group MRPMutual Recognition Procedure NASNew Active Substance NCENew Chemical Entity NDANew Drug Application new chemical entities (NCEs) new drug applications (NDAs)

NSAID Non Steroidal Anti Inflammatory Drug NTA Notice To Applicants OOS Out of Specification OTC Over The Counter

PAGB Proprietary Association of Great Britain Ph Eur European Pharmacopoeia PIL Patient Information Leaflet PL Product Licence

POM Prescription Only Medicine PRODUCT OWNER

PSU Periodic Safety Updates QA Quality Assurance QC Quality Control

RAJ Regulatory Affairs Journal RMS Reference Member State RMS相互认可另一成员国

RSD Relative Standard Deviation Rx Prescription Only

SAE Serious Adverse Event SMF Site Master File

SOP Standard Operating Procedure

SOP (STANDARD OPERATION PROCEDURE) 标准运作程序 SPC/SmPC Summary of Product Characteristics summary of product characteristics(SPC)

Therapeutic Goods Administration (TGA) USP US Pharmacopoeia

VMF Veterinary Master File

VPC Veterinary Products Committee

A.A.A Addition and Amendments 增补和修订 AC Air Conditioner 空调器

ADR Adverse Drug Reaction 药物不良反应

AFDO Association of Food and Drug Officials 食品与药品协会(美国) ACC Accept 接受

AQL Acceptable Quality Level 合格质量标准

ADNA Abbreviated New Drug Application 简化的新药申请 BOM Bill of Material 物料清单

BPC Bulk pharmaceutical Chemiclls 原料药

CBER Center for Biologics Evaluation Research 生物制品评价与研究中心 CFU Colony Forming Unet 菌落形成单位 DMF Drug Master File 药品管理档案

CDER Cemter for Drug Evaluation amd Research 药物评价与研究中心 CI Corporate Identity (Image) 企业识别(形象) CIP Cleaning in Place 在线清洗

CSI Consumer Safety Insepctor 消费者安全调查员 CLP Cleaning Line Procedure 在线清洗程序 DAL Defect Action Level 缺陷作用水平

DEA Drug Enforcement Adminestration 管制药品管理 DS Documentation Systim 文件系统

FDA Food and Drug Administration 食品与药品管理局(美国) GATT General Agreemernt on Tariffs and Trade 关贸总协会 GMP Good Manufacturing Practice Gvp 药品生质量管理规范 GCP Good Clinical Practice 药品临床实验管理规范 GLP Good Laboratory Practice 实验室管理规范 GSP Good Supply Practice 药品商业质量规范

GRP Gook RaTAIL Practice 药品零业质量管理规范 GAP Good Agriculture Practice 药材生产管理规范 GVP Gook Validation Prctice 验证管理规范 GUP Gook Use Practice 药品重用规范

HVAC Heating Ventilation Air Conditioning 空调净化系统

ISO Intematonal Organization for Standardization 车际标准化组织 MOU Memorandum of Understanding 谅解备忘录 PF Porduction File 生产记录用表格

OTC Over the Counter (Drug) 非处方药品

PLA Product License Application 产品许可申请 QA Quality Assurance 质量保证 QC Quality Control 质量控制

QMP Quality Management Procedure 质量管理程序 SDA State Drug Administration 国家药品监督管理局

SMP Standard Managmert Procedure 标准管理程序 SOP Standard Operating Procedure 标准操作程序 TQC Tatal Quality Control 全面质量管理 USA Uneted States Pharmacopeia 美国药典 -- 作者:月萝兰魂

-- 发布时间:2006-12-22 13:35:00 --

ICH 安全性领域常用专业术语中英文对照表 Dead offspring at birth 出生时死亡的子代

Degradation 降解 Delay of parturition 分娩延迟

Deletion 缺失 Descriptive statistics 描述性统计 Distribution 分布

Detection of bacterial mutagen 细菌诱变剂检测 Detection of clastogen 染色体断裂剂检测

Determination of metabolites 测定代谢产物 Development of the offspring 子代发育 Developmental toxicity 发育毒性 Diminution of the background lawn 背景减少 Direct genetic damage 直接遗传损伤 DNA adduct DNA加合物 DNA damage DNA损伤

DNA repair DNA修复 DNA strand breaks DNA链断裂

Dose escalation 剂量递增 Dose dependence 剂量依赖关系 Dose level 剂量水平 Dose-limiting toxicity 剂量性毒性 Dose-raging studies 剂量范围研究 Dose-relatived mutagenicity 剂量相关性诱变性 Dose-related 剂量相关 Dose-relatived cytotoxicity 剂量相关性细胞毒性

Dose-relatived genotoxic activity 剂量相关性遗传毒性 Dose-response curve 剂量-反应曲线 Dosing route 给药途径 Duration 周期 Duration of pregnancy 妊娠周期

Eaning 断奶 Earlier physical malformation 早期躯体畸形 Early embryonic development 早期胚胎发育

Early embryonic development to implantation 着床早期的胚胎发育 Electro ejaculation 电射精 Elimination 清除

Embryofetal deaths 胚胎和胎仔死亡 Embryo-fetal development 胚胎-胎仔发育 Embryo-fetal toxicity 胚胎-胎仔毒性 Embryonic death 胚胎死亡 Embryonic development 胚胎发育 Embryonic period 胚胎期 Embryos 胚胎 Embryotoxicity 胚胎毒性 Enantiomer 对映异构体

End of pregnancy 怀孕终止 Endocytic 内吞噬(胞饮)

Endocytic activity 内吞噬活性 Endogenous proteins 内源性蛋白 Endogenous components 内源性物质 Endogenous gene 内源性基因

Endonuclease 核酸内切酶 Emdpmiclease release from lysosomes 溶酶体释放核酸内切酶

End-point 终点

Epididymal sperm maturation 附睾精子成熟性 Epitope 抗原决定部位 Error prone repair 易错性修复 Escalation 递增

Escherichia coli strain 大肠杆菌菌株 Escherichia coli 大肠杆菌

Evaluation of test result 试验结果评价

Exaggerated pharmacological response 超常增强的药理作用 Excretion 排泄(清除) Exposure assessment 接触剂量评价

Exposure period 接解期 External metabolizing system 体外代谢系统 F1-animals 子一代动物

False positive result 假阳性结果

Fecundity 多产 Feed-back 反馈 Fertilisation 受精 Fertility 生育力 Fertility studies 生育力研究 Fetal abnormalities 胎仔异常 Fetal and neonatal parameters 胎仔和仔鼠的生长发育参数

Fetal development and growth 肿仔发育和生长 Fetal period 胎仔期 Fetotoxicity 胎仔毒性

False negative result 假阴性结果First pass testing 一期试验 Fluorescence in situ hybridization(FISH) 原位荧光分子杂交 -- 作者:月萝兰魂

-- 发布时间:2006-12-22 13:35:00 --

average deviation 平均差 B

bar chart 直条图,条图 bias 偏性

binomial distribution 二项分布 biometrics 生物统计学

bivariate normal population 双变量正态总体 C

cartogram 统计图

case fatality rate(or case mortality) 病死率 census 普查

chi-sguare(X2) test 卡方检验 central tendency 集中趋势 class interval 组距

classification 分组,分类 cluster sampling 整群抽样

coefficient of correlation 相关系数 coefficient of regression 回归系数

coefficient of variability(or coefficieut of variation) 变异系数 collection of data 收集资料 column 列(栏)

combinative table 组合表

combined standard deviation 合并标准差

combined variance(or poolled variance) 合并方差 complete survey 全面调查

completely correlation 完全相关

completely random design 完全随机设计 confidence level 可信水平,置信水平

confidence limit 可信限,置信限

constituent ratio 构成比,结构相对数 continuity 连续性 control 对照

control group 对照组 coordinate 坐标

correction for continuity 连续性校正 correction for grouping 归组校正 correction number 校正数 correction value 校正值 correlation 相关,联系

correlation analysis 相关分析 correlation coefficient 相关系数 critical value 临界值

cumulative frequency 累积频率 D

data 资料

degree of dispersion 离散程度 degree of freedom 自由度 degree of variation 变异度 dependent variable 应变量

design of experiment 实验设计 deviation from the mean 离均差

diagnose accordance rate 诊断符合率

difference with significance 差别不显著 difference with significance 差别显著 discrete variable 离散变量 dispersion tendency 离中趋势 distribution 分布,分配 -- 作者:月萝兰魂

-- 发布时间:2006-12-22 13:35:00 -- E

effective rate 有效率 eigenvalue 特征值

enumeration data 计数资料

equation of linear regression 线性回归方程 error 误差

error of replication 重复误差 estimate value 估计值 event 事件

experiment design 实验设计 experiment error 实验误差 experimental group 实验组

extreme value 极值 F

fatality rate 病死率 field survey 现场调查 fourfold table 四格表 freguency 频数

freguency distribution 频数分布 G

Gaussian curve 高斯曲线 geometric mean 几何均数 grouped data 分组资料 H

histogram 直方图

homogeneity of variance 方差齐性

homogeneity test of variances 方差齐性检验 hypothesis test 假设检验

hypothetical universe 假设总体 I

incidence rate 发病率

incomplete survey 非全面调检 indepindent variable 自变量 indivedual difference 个体差异 infection rate 感染率 inferior limit 下限 initial data 原始数据

inspection of data 检查资料 intercept 截距

interpolation method 内插法 interval estimation 区间估计 inverse correlation 负相关 K

kurtosis coefficient 峰度系数 L

latin sguare design 拉丁方设计

least significant difference 最小显著差数 least square method 最小平方法,最小乘法 leptokurtic distribution 尖峭态分布 leptokurtosis 峰态,峭度 linear chart 线图

linear correlation 直线相关 linear regression 直线回归

linear regression eguation 直线回归方程 link relative 环比

logarithmic normal distribution 对数正态分布

logarithmic scale 对数尺度

lognormal distribution 对数正态分布 lower limit 下限 M

matched pair design 配对设计

mathematical statistics 数理统计(学) maximum value 极大值 mean 均值

mean of population 总体均数 mean square 均方

mean variance 均方,方差 measurement data 讲量资料 median 中位数

medical statistics 医学统计学 mesokurtosis 正态峰

method of least squares 最小平方法,最小乘法 method of grouping 分组法

method of percentiles 百分位数法 mid-value of class 组中值 minimum value 极小值 mode 众数

moment 动差,矩 morbidity 患病率 mortality 死亡率 N

natality 出生率

natural logarithm 自然对数 negative correlation 负相关 negative skewness 负偏志 no correlation 无相关

non-linear correlation 非线性相关 non-parametric statistics 非参数统计 normal curve 正态曲线 normal deviate 正态离差

normal distribution 正态分布 normal population 正态总体

normal probability curve 正态概率曲线 normal range 正常范围 normal value 正常值 normal kurtosis 正态峰 normality test 正态性检验 nosometry 患病率 -- 作者:月萝兰魂

-- 发布时间:2006-12-22 13:35:00

-- O

observed unit 观察单位 observed value 观察值 one-sided test 单测检验 one-tailed test 单尾检验 order statistic 顺序统计量 ordinal number 秩号 ordinate 纵坐标 P

pairing data 配对资料 parameter 参数 percent 百分率

percentage 百分数,百分率

percentage bar chart 百分条图 percentile 百分位数 pie diagram 园图 placebo 安慰剂

planning of survey 调查计划 point estimation 点估计 population 总体,人口

population mean 总体均数 population rate 总体率

population variance 总体方差 positive correlation 正相关 positive skewness 正偏态 prevalence rate 患病率 probability 概率,机率

probability error 偶然误差 proportion 比,比率

prospective study 前瞻研究 prospective survey 前瞻调查

public health statistics 卫生统计学 Q

quality eontrol 质量控制 quartile 四分位数 R

random 随机

random digits 随机数字

random numbers table 随机数目表 random sample 随机样本 random sampling 随机抽样 random variable 随机变量 randomization 随机化

randomized blocks 随机区组,随机单位组

randomized blocks analysis of variance 随机单位组方差分析 randomized blocks design 随机单位组设计 randomness 随机性 range 极差,全距

range of normal values 正常值范围 rank 秩,秩次,等级

rank correlation 等级相关

rank correlation coefficent 等级相关系数 rank-sum test 秩和检验 ranked data 等级资料 rate 率 ratio 比

recovery rate 治愈率 registration 登记 regression 回归

regression analysis 回归分析 regression coefficient 回归系数 regression eguation 回归方程 relative number 相对数 relative ratio 比较相对数

relative ratio with fixed base 定基比 remainder error 剩余误差 replication 重复

retrospective survey 回顾调查 Ridit analysis 参照单位分析 Ridit value 参照单位值 S

sample 样本

sample average 样本均数 sample size 样本含量 sampling 抽样

sampling error 抽样误差

sampling statistics 样本统计量 sampling survay 抽样调查 scaller diagram 散点图 schedule of survey 调查表

semi-logarithmic chart 半对数线图 semi-measursement data 半计量资料 semi-guartile range 四分位数间距 sensitivity 灵敏度 sex ratio 性比例 sign test 符号检验

significance 显著性,意义

significance level 显著性水平 significance test 显著性检验 significant difference 差别显著

simple random sampling 单纯随机抽样 simple table 简单表

size of sample 样本含量 skewness 偏态 slope 斜率

sorting data 整理资料 sorting table 整理表

sources of variation 变异来源 square deviation 方差

standard deviation(SD) 标准差 standard error (SE) 标准误

standard error of estimate 标准估计误差 standard error of the mean 均数的标准误 standardization 标准化 standardized rate 标化率

standardized normal distribution 标准正态分布 statistic 统计量 statistics 统计学

statistical induction 统计图 statistical inference 统计归纳 statistical map 统计推断 statistical method 统计地图 statistical survey 统计方法 statistical table 统计调查 statistical test 统计表

statistical treatment 统计检验 stratified sampling 统计处理 stochastic variable 分层抽样

sum of cross products of 随机变量 deviation from mean 离均差积和 sum of ranks 秩和

sum of sguares of deviation from mean 离均差平方和 superior limit 上限survival rate 生存率 symmetry 对称(性)

systematic error 系统误差 systematic sampling 机械抽样 -- 作者:月萝兰魂

-- 发布时间:2006-12-22 13:35:00 -- T

t-distribution t分布

t-test t检验

tabulation method 划记法

test of normality 正态性检验 test of one-sided 单侧检验 test of one-tailed 单尾检验

test of significance 显著性检验 test of two-sided 双侧检验 test of two-tailed 双尾检验 theoretical frequency 理论频数 theoretical number 理论数 treatment 处理

treatment factor 处理因素 treatment of date 数据处理

two-factor analysis of variance 双因素方差分析 two-sided test 双侧检验 two-tailed test 双尾检验 type I error 第一类误差 type II error 第二类误差 typical survey 典型调查 U

u test u检验

universe 总体,全域

ungrouped data 未分组资料 upper limit 上限 V

variable 变量

variance 方差,均方

variance analysis 方差分析 variance ratio 方差比 variate 变量

variation coefficient 变异系数 velocity of development 发展速度 velocity of increase 增长速度 W

weight 权数

weighted mean 加权均数 Z

zero correlation 零相关 -- 作者:月萝兰魂

-- 发布时间:2006-12-22 13:36:00 --

世界500强制药企业名称中英对照

排名 公司名称中文名称 总部 收入百万美元 77 Pfizer 辉瑞 美国 45950.0

92 Johnson & Johnson 强生 美国 41862.0

114 GlaxoSmithKline 葛兰素史克 英国 35050.9 193 Novartis 诺华 瑞士 248.0 205 Roche Group 罗氏 瑞士 23212.9 222 Merck 默克 美国 22485.9

239 Bristol-Myers Squibb 百时美施贵宝 美国 204.0 248 Aventis 安万特 法国 20162.4

254 Abbott Laboratories 雅培 美国 19680.6 269 AstraZeneca 阿斯利康 英国 18849.0 330 Wyeth 惠氏 美国 15850.6

433 Eli Lilly 礼来大药厂 美国 12582.5 100 BASF 巴斯夫 德国 37757.0

125 Dow Chemical 道化学 美国 32632.0 129 Bayer 拜耳 德国 32331.1

365 Akzo Nobel 阿克苏诺贝尔 荷兰 14770.7